Riggs Asset Managment »

Oncocyte Corporation shares owned by Riggs Asset Managment

Quarter-by-quarter ownership of Oncocyte Corporation (OCX) shares owned by Riggs Asset Managment from 13F filings

Historical chart of Riggs Asset Managment investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by Riggs Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by Riggs Asset Managment

Quarter filed Position value Share count Share price at filing
2024-03-31 $147 50 2.94
2023-12-31 $125 50 2.50
2023-09-30 $156 50 3.12

More positions owned by Riggs Asset Managment

Global X Fds Us Infr Dev Etf (PAVE)
Ishares Tr Us Home Cons Etf (ITB)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Expanded Tech (IGV)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Rba Indl Etf (AIRR)
Ishares Tr Core S&p Mcp Etf (IJH)
Visa Com Cl A (V)
Select Sector Spdr Tr Energy (XLE)
Alps Etf Tr Alerian Mlp (AMLP)
Apple (AAPL)
Asml Holding N V N Y Registry Shs (ASML)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Vaneck Etf Trust Steel Etf (SLX)

View all positions for Riggs Asset Managment

Top funds holding Oncocyte Corporation

Vanguard Group
UBS Group
Royal Bank of Canada
Pnc Financial Services
Bank of America Corporation
Jpmorgan Chase & Co
Nbc Securities
Advisor Group Holdings
Rhumbline Advisers
Wells Fargo & Company
Riggs Asset Managment
Piscataqua Savings Bank
Coppell Advisory Solutions
Albion Financial Group

View all funds holding Oncocyte Corporation